DPO-1

1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

DPO-1 is a potent Kv1.5 and Kv1.3 (EC50 = 3.1 μM) channels inhibitor with potential immunomodulatory and anti-inflammatory effects. DPO-1 reduces Kv1.3 current density, blunts Ca2+ influx in Ca2+-depleted Jurkat cells, and inhibits IL-2 secretion in activated Jurkat cells. DPO-1 inhibits Uric acid sodium (HY-B2130A) (MSU)-induced NLRP3 inflammasome activation by blocking Kv1.5-mediated K+ efflux. DPO-1 can be used for the study of immunologic disorders and atrial fibrillation.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98.39%
  • CAS. Nr.: 43077-30-1
  • Formel: C22H29OP
  • Molecular Weight:340.44
  • Speicherung:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) DPO-1

More

Alle NOD-like Receptor (NLR) Isoform-spezifische Produkte anzeigen

More

Alle Interleukin Related Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00